logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Pregnancy

    Medications for Pregnancy

    FiltersReset Filters
    100 results

    • ashlyna

      (Levonorgestrel and Ethinyl Estradiol and Ethinyl Estradiol)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Ashlyna is indicated for use in females of reproductive potential to prevent pregnancy.

    • aviane

      (Levonorgestrel and Ethinyl Estradiol)
      Teva Pharmaceuticals USA, Inc.
      Usage: Aviane, containing levonorgestrel and ethinyl estradiol, is indicated for preventing pregnancy in females of reproductive potential. Its efficacy is not adequately evaluated in women with a BMI over 35 kg/m². In trials, it had a pregnancy rate of 0.84 per 100 woman-years with noted compliance issues.

    • carboprost tromethamine

      (carboprost tromethamine)
      SOLA Pharmaceuticals, LLC
      Usage: Carboprost tromethamine injection is indicated for aborting pregnancies between the 13th and 20th weeks, addressing complications like failed expulsion or ruptured membranes. It is also used to treat postpartum hemorrhage due to uterine atony that hasn't responded to standard treatments, helping to control life-threatening bleeding.

    • carboprost tromethamine

      (carboprost tromethamine)
      Xellia Pharmaceuticals USA LLC
      Usage: Carboprost tromethamine injection is indicated for aborting pregnancies between the 13th and 20th weeks and for treating postpartum hemorrhage due to uterine atony unresponsive to conventional management. It addresses fetal expulsion failures and specific complications during second-trimester abortions and helps control severe bleeding after childbirth.

    • carboprost tromethamine

      (Carboprost Tromethamine)
      ANI Pharmaceuticals Inc
      Usage: Carboprost tromethamine injection is indicated for aborting pregnancy between the 13th and 20th weeks, addressing conditions such as failure of fetal expulsion and premature membrane rupture. It is also used to treat postpartum hemorrhage due to uterine atony unresponsive to conventional management.

    • charlotte 24fe

      (norethindrone acetate and ethinyl estradiol and ferrous fumarate)
      Glenmark Pharmaceuticals Inc., USA
      Usage: Charlotte 24 Fe is indicated for use in females of reproductive age to prevent pregnancy. Its efficacy has not been evaluated in women with a body mass index (BMI) greater than 35 kg/m².

    • chlorthalidone

      (Chlorthalidone)
      Sun Pharmaceutical Industries, Inc.
      Usage: Chlorthalidone is indicated for managing hypertension, either alone or with other antihypertensive agents. It serves as adjunctive therapy for edema due to congestive heart failure, hepatic cirrhosis, and renal dysfunction. In pregnancy, it may be used for pathologic edema, but not routinely for general edema.

    • cryselle

      (Norgestrel and Ethinyl Estradiol)
      Teva Pharmaceuticals USA, Inc.
      Usage: Cryselle is indicated for females of reproductive potential to prevent pregnancy, demonstrating a pregnancy rate of approximately 1 per 100 women-years among users aged 15 to 40 years in a study involving 1,287 women.

    • dasetta 1/35

      (Norethindrone and Ethinyl Estradiol)
      Northstar Rx LLC
      Usage: DASETTA™ 1/35 tablets are indicated for the prevention of pregnancy in women choosing this method of contraception. Effective when used consistently and correctly, it serves as a reliable option among various contraceptive methods but is not for emergency contraception.

    • dasetta 7/7/7

      (norethindrone and ethinyl estradiol)
      Northstar Rx LLC
      Usage: DASETTA™ 7/7/7 Tablets are indicated for the prevention of pregnancy in women choosing this method of contraception. They are considered highly effective when used correctly and consistently, though they are not studied for or indicated for emergency contraception.
      • ...